Koronis Pharmaceuticals to Participate in Panel 'Infectious ... (Chronic Hepatitis C)

Koronis Pharmaceuticals to Participate in Panel 'Infectious ...
PharmaLive.com (press release), PA - Feb 10, 2006... to the Company's lead product candidate, KP-1461 for AIDS/HIV, the Company has product candidates in development for the treatment of hepatitis C infection. ...

Schering-Plough drug gets fast track
BusinessWeek - Jan 30, 2006... The drug, known as SCH 503034, is an oral therapy in mid-stage human studies testing it as a treatment for chronic hepatitis C infection. ...

ZymoGenetics Reports Fourth Quarter and Year End 2005 Financial ...
PR Newswire (press release), NY - Feb 9, 2006... Other -- The company decided to advance Interleukin-29 (IL-29) into clinical development as a potential treatment for Hepatitis C infection. ...

New drug abuse team will tackle growing problem 'top to bottom'
Ottawa Citizen, Canada - Feb 10, 2006Ottawa's injection drug users have the highest hepatitis C infection rates in Canada, nine times higher than those in Toronto and the same as Vancouver's drug ...